Sepsis and the heart

被引:180
作者
Hunter, J. D. [1 ]
Doddi, M. [1 ]
机构
[1] Macclesfield Hosp, Macclesfield SK10 3BL, Cheshire, England
关键词
complications; hypotension; infection; heart; myocardial function; immune response; polypeptides; cytokines; CRITICALLY-ILL PATIENTS; NITRIC-OXIDE SYNTHASE; MYOCARDIAL DEPRESSANT SUBSTANCE; RIGHT-VENTRICULAR PERFORMANCE; SEPTIC SHOCK PATIENTS; NECROSIS-FACTOR-ALPHA; RAT CARDIAC MYOCYTES; TROPONIN-I; SEPSIS/SEPTIC SHOCK; DIASTOLIC FUNCTION;
D O I
10.1093/bja/aep339
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Septic shock, the most severe complication of sepsis, accounts for similar to 10% of all admissions to intensive care. Our understanding of its complex pathophysiology remains incomplete but clearly involves stimulation of the immune system with subsequent inflammation and microvascular dysfunction. Cardiovascular dysfunction is pronounced and characterized by elements of hypovolaemic, cytotoxic, and distributive shock. In addition, significant myocardial depression is commonly observed. This septic cardiomyopathy is characterized by biventricular impairment of intrinsic myocardial contractility, with a subsequent reduction in left ventricular (LV) ejection fraction and LV stroke work index. This review details the myocardial dysfunction observed in adult septic shock, and discusses the underlying pathophysiology. The utility of using the regulatory protein troponin for the detection of myocardial dysfunction is also considered. Finally, options for the management of sepsis-induced LV hypokinesia are discussed, including the use of levosimendan.
引用
收藏
页码:3 / 11
页数:9
相关论文
共 111 条
[11]   Myocardial dysfunction in sepsis: no role for NO? [J].
Belcher, E ;
Mitchell, J ;
Evans, T .
HEART, 2002, 87 (06) :507-509
[12]   INCREASE OF MYOCARDIAL INHIBITORY G-PROTEINS IN CATECHOLAMINE-REFRACTORY SEPTIC SHOCK OR IN SEPTIC MULTIORGAN FAILURE [J].
BOHM, M ;
KIRCHMAYR, R ;
GIERSCHIK, P ;
ERDMANN, E .
AMERICAN JOURNAL OF MEDICINE, 1995, 98 (02) :183-186
[13]   DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS [J].
BONE, RC ;
BALK, RA ;
CERRA, FB ;
DELLINGER, RP ;
FEIN, AM ;
KNAUS, WA ;
SCHEIN, RMH ;
SIBBALD, WJ .
CHEST, 1992, 101 (06) :1644-1655
[14]   Isolated and reversible impairment of ventricular relaxation in patients with septic shock [J].
Bouhemad, Belaid ;
Nicolas-Robin, Armelle ;
Arbelot, Charlotte ;
Arthaud, Martine ;
Feger, Frederic ;
Rouby, Jean-Jacques .
CRITICAL CARE MEDICINE, 2008, 36 (03) :766-774
[15]  
BRADY AJB, 1993, BRIT HEART J, V70, P103
[16]   NITRIC-OXIDE ATTENUATES CARDIAC MYOCYTE CONTRACTION [J].
BRADY, AJB ;
WARREN, JB ;
POOLEWILSON, PA ;
WILLIAMS, TJ ;
HARDING, SE .
AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 265 (01) :H176-H182
[17]   Brain natriuretic peptide: A marker of myocardial dysfunction and prognosis during severe sepsis [J].
Charpentier, J ;
Luyt, CE ;
Fulla, Y ;
Vinsonneau, C ;
Cariou, A ;
Grabar, S ;
Dhainaut, JF ;
Mira, JP ;
Chiche, JD .
CRITICAL CARE MEDICINE, 2004, 32 (03) :660-665
[18]   MECHANISM OF CYTOKINE INHIBITION OF BETA-ADRENERGIC AGONIST STIMULATION OF CYCLIC-AMP IN RAT CARDIAC MYOCYTES - IMPAIRMENT OF SIGNAL TRANSDUCTION [J].
CHUNG, MK ;
GULICK, TS ;
ROTONDO, RE ;
SCHREINER, GF ;
LANGE, LG .
CIRCULATION RESEARCH, 1990, 67 (03) :753-763
[19]   CIRCULATORY AND METABOLIC ALTERATIONS ASSOCIATED WITH SURVIVAL OR DEATH IN PERITONITIS - CLINICAL ANALYSIS OF 25 CASES [J].
CLOWES, GHA ;
VUCINIC, M ;
WEIDNER, MG .
ANNALS OF SURGERY, 1966, 163 (06) :866-&
[20]   THE CORONARY CIRCULATION IN HUMAN SEPTIC SHOCK [J].
CUNNION, RE ;
SCHAER, GL ;
PARKER, MM ;
NATANSON, C ;
PARRILLO, JE .
CIRCULATION, 1986, 73 (04) :637-644